aluates Reports

$ 0.0

Automative

Global Biotechnological Drugs Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-11U9794

Global Biotechnological Drugs Market Research Report 2022

BUY CHAPTERS

Global Biotechnological Drugs Market Research Report 2025

Code: QYRE-Auto-11U9794

Report

February 2025

Pages:95

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

3SBio Inc

Anhui Anke Biotechnology

Beijing SL Pharmaceutical

Biotech Pharmaceutical

Cadila Healthcare

Celgen Biopharma

Celltrion

Dr. Reddy's

GeneScience Pharmaceuticals

Hisun Pharma

Jiangsu Sihuan Bioengineering

Novartis (Sandoz)

Pfizer (Hospira)

Shanghai Lansheng Guojian Pharmaceutical

Shenzhen Neptunus Interlong Bio-Technique

Tonghua Dongbao Pharmaceutical

Torrent Pharmaceuticals

Biotechnological Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Biotechnological Drugs Market

The global market for Biotechnological Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Biotechnological Drugs, also known as biologics, are pharmaceutical products derived from living organisms using biotechnology techniques. These drugs can include vaccines, monoclonal antibodies, and gene therapies.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Biotechnological Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biotechnological Drugs.

The Biotechnological Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biotechnological Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biotechnological Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Biotechnological Drugs Market Report

Report Metric	Details
Report Name	Biotechnological Drugs Market
CAGR	5%
Segment by Type	Genetically Engineered Drugs Therapeutic Monoclonal Antibody Drugs Gene Therapy and Nucleic Acid Drugs Genetically Engineered Vaccines Other
Segment by Application	Tumor Autoimmune Disease Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	3SBIO, Anhui Anke Biotechnology, Beijing SL Pharmaceutical, Biotech Pharmaceutical, Cadila Healthcare, Celgen Biopharma, Celltrion, Dr Reddy’s, GeneScience Pharmaceuticals, Hisun Pharma, Jiangsu Sihuan Bioengineering, Novartis (Sandoz), Pfizer (Hospira), Shanghai Lansheng Guojian Pharmaceutical, Shenzhen Neptunus Interlong Bio-Technique, Tonghua Dongbao Pharmaceutical, Torrent Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biotechnological Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Biotechnological Drugs Market report?

Ans: The main players in the Biotechnological Drugs Market are 3SBIO, Anhui Anke Biotechnology, Beijing SL Pharmaceutical, Biotech Pharmaceutical, Cadila Healthcare, Celgen Biopharma, Celltrion, Dr Reddy’s, GeneScience Pharmaceuticals, Hisun Pharma, Jiangsu Sihuan Bioengineering, Novartis (Sandoz), Pfizer (Hospira), Shanghai Lansheng Guojian Pharmaceutical, Shenzhen Neptunus Interlong Bio-Technique, Tonghua Dongbao Pharmaceutical, Torrent Pharmaceuticals

What are the Application segmentation covered in the Biotechnological Drugs Market report?

Ans: The Applications covered in the Biotechnological Drugs Market report are Tumor, Autoimmune Disease, Other

What are the Type segmentation covered in the Biotechnological Drugs Market report?

Ans: The Types covered in the Biotechnological Drugs Market report are Genetically Engineered Drugs, Therapeutic Monoclonal Antibody Drugs, Gene Therapy and Nucleic Acid Drugs, Genetically Engineered Vaccines, Other

Recommended Reports

Drug Development

Diagnostics & Testing

Biopharma Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biotechnological Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Genetically Engineered Drugs

1.2.3 Therapeutic Monoclonal Antibody Drugs

1.2.4 Gene Therapy and Nucleic Acid Drugs

1.2.5 Genetically Engineered Vaccines

1.2.6 Other

1.3 Market by Application

1.3.1 Global Biotechnological Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Tumor

1.3.3 Autoimmune Disease

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biotechnological Drugs Market Perspective (2020-2031)

2.2 Global Biotechnological Drugs Growth Trends by Region

2.2.1 Global Biotechnological Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Biotechnological Drugs Historic Market Size by Region (2020-2025)

2.2.3 Biotechnological Drugs Forecasted Market Size by Region (2026-2031)

2.3 Biotechnological Drugs Market Dynamics

2.3.1 Biotechnological Drugs Industry Trends

2.3.2 Biotechnological Drugs Market Drivers

2.3.3 Biotechnological Drugs Market Challenges

2.3.4 Biotechnological Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biotechnological Drugs Players by Revenue

3.1.1 Global Top Biotechnological Drugs Players by Revenue (2020-2025)

3.1.2 Global Biotechnological Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Biotechnological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Biotechnological Drugs Revenue

3.4 Global Biotechnological Drugs Market Concentration Ratio

3.4.1 Global Biotechnological Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biotechnological Drugs Revenue in 2024

3.5 Global Key Players of Biotechnological Drugs Head office and Area Served

3.6 Global Key Players of Biotechnological Drugs, Product and Application

3.7 Global Key Players of Biotechnological Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Biotechnological Drugs Breakdown Data by Type

4.1 Global Biotechnological Drugs Historic Market Size by Type (2020-2025)

4.2 Global Biotechnological Drugs Forecasted Market Size by Type (2026-2031)

5 Biotechnological Drugs Breakdown Data by Application

5.1 Global Biotechnological Drugs Historic Market Size by Application (2020-2025)

5.2 Global Biotechnological Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Biotechnological Drugs Market Size (2020-2031)

6.2 North America Biotechnological Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Biotechnological Drugs Market Size by Country (2020-2025)

6.4 North America Biotechnological Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biotechnological Drugs Market Size (2020-2031)

7.2 Europe Biotechnological Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Biotechnological Drugs Market Size by Country (2020-2025)

7.4 Europe Biotechnological Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Biotechnological Drugs Market Size (2020-2031)

8.2 Asia-Pacific Biotechnological Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Biotechnological Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Biotechnological Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Biotechnological Drugs Market Size (2020-2031)

9.2 Latin America Biotechnological Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Biotechnological Drugs Market Size by Country (2020-2025)

9.4 Latin America Biotechnological Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biotechnological Drugs Market Size (2020-2031)

10.2 Middle East & Africa Biotechnological Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Biotechnological Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Biotechnological Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 3SBIO

11.1.1 3SBIO Company Details

11.1.2 3SBIO Business Overview

11.1.3 3SBIO Biotechnological Drugs Introduction

11.1.4 3SBIO Revenue in Biotechnological Drugs Business (2020-2025)

11.1.5 3SBIO Recent Development

11.2 Anhui Anke Biotechnology

11.2.1 Anhui Anke Biotechnology Company Details

11.2.2 Anhui Anke Biotechnology Business Overview

11.2.3 Anhui Anke Biotechnology Biotechnological Drugs Introduction

11.2.4 Anhui Anke Biotechnology Revenue in Biotechnological Drugs Business (2020-2025)

11.2.5 Anhui Anke Biotechnology Recent Development

11.3 Beijing SL Pharmaceutical

11.3.1 Beijing SL Pharmaceutical Company Details

11.3.2 Beijing SL Pharmaceutical Business Overview

11.3.3 Beijing SL Pharmaceutical Biotechnological Drugs Introduction

11.3.4 Beijing SL Pharmaceutical Revenue in Biotechnological Drugs Business (2020-2025)

11.3.5 Beijing SL Pharmaceutical Recent Development

11.4 Biotech Pharmaceutical

11.4.1 Biotech Pharmaceutical Company Details

11.4.2 Biotech Pharmaceutical Business Overview

11.4.3 Biotech Pharmaceutical Biotechnological Drugs Introduction

11.4.4 Biotech Pharmaceutical Revenue in Biotechnological Drugs Business (2020-2025)

11.4.5 Biotech Pharmaceutical Recent Development

11.5 Cadila Healthcare

11.5.1 Cadila Healthcare Company Details

11.5.2 Cadila Healthcare Business Overview

11.5.3 Cadila Healthcare Biotechnological Drugs Introduction

11.5.4 Cadila Healthcare Revenue in Biotechnological Drugs Business (2020-2025)

11.5.5 Cadila Healthcare Recent Development

11.6 Celgen Biopharma

11.6.1 Celgen Biopharma Company Details

11.6.2 Celgen Biopharma Business Overview

11.6.3 Celgen Biopharma Biotechnological Drugs Introduction

11.6.4 Celgen Biopharma Revenue in Biotechnological Drugs Business (2020-2025)

11.6.5 Celgen Biopharma Recent Development

11.7 Celltrion

11.7.1 Celltrion Company Details

11.7.2 Celltrion Business Overview

11.7.3 Celltrion Biotechnological Drugs Introduction

11.7.4 Celltrion Revenue in Biotechnological Drugs Business (2020-2025)

11.7.5 Celltrion Recent Development

11.8 Dr Reddy’s

11.8.1 Dr Reddy’s Company Details

11.8.2 Dr Reddy’s Business Overview

11.8.3 Dr Reddy’s Biotechnological Drugs Introduction

11.8.4 Dr Reddy’s Revenue in Biotechnological Drugs Business (2020-2025)

11.8.5 Dr Reddy’s Recent Development

11.9 GeneScience Pharmaceuticals

11.9.1 GeneScience Pharmaceuticals Company Details

11.9.2 GeneScience Pharmaceuticals Business Overview

11.9.3 GeneScience Pharmaceuticals Biotechnological Drugs Introduction

11.9.4 GeneScience Pharmaceuticals Revenue in Biotechnological Drugs Business (2020-2025)

11.9.5 GeneScience Pharmaceuticals Recent Development

11.10 Hisun Pharma

11.10.1 Hisun Pharma Company Details

11.10.2 Hisun Pharma Business Overview

11.10.3 Hisun Pharma Biotechnological Drugs Introduction

11.10.4 Hisun Pharma Revenue in Biotechnological Drugs Business (2020-2025)

11.10.5 Hisun Pharma Recent Development

11.11 Jiangsu Sihuan Bioengineering

11.11.1 Jiangsu Sihuan Bioengineering Company Details

11.11.2 Jiangsu Sihuan Bioengineering Business Overview

11.11.3 Jiangsu Sihuan Bioengineering Biotechnological Drugs Introduction

11.11.4 Jiangsu Sihuan Bioengineering Revenue in Biotechnological Drugs Business (2020-2025)

11.11.5 Jiangsu Sihuan Bioengineering Recent Development

11.12 Novartis (Sandoz)

11.12.1 Novartis (Sandoz) Company Details

11.12.2 Novartis (Sandoz) Business Overview

11.12.3 Novartis (Sandoz) Biotechnological Drugs Introduction

11.12.4 Novartis (Sandoz) Revenue in Biotechnological Drugs Business (2020-2025)

11.12.5 Novartis (Sandoz) Recent Development

11.13 Pfizer (Hospira)

11.13.1 Pfizer (Hospira) Company Details

11.13.2 Pfizer (Hospira) Business Overview

11.13.3 Pfizer (Hospira) Biotechnological Drugs Introduction

11.13.4 Pfizer (Hospira) Revenue in Biotechnological Drugs Business (2020-2025)

11.13.5 Pfizer (Hospira) Recent Development

11.14 Shanghai Lansheng Guojian Pharmaceutical

11.14.1 Shanghai Lansheng Guojian Pharmaceutical Company Details

11.14.2 Shanghai Lansheng Guojian Pharmaceutical Business Overview

11.14.3 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Introduction

11.14.4 Shanghai Lansheng Guojian Pharmaceutical Revenue in Biotechnological Drugs Business (2020-2025)

11.14.5 Shanghai Lansheng Guojian Pharmaceutical Recent Development

11.15 Shenzhen Neptunus Interlong Bio-Technique

11.15.1 Shenzhen Neptunus Interlong Bio-Technique Company Details

11.15.2 Shenzhen Neptunus Interlong Bio-Technique Business Overview

11.15.3 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Introduction

11.15.4 Shenzhen Neptunus Interlong Bio-Technique Revenue in Biotechnological Drugs Business (2020-2025)

11.15.5 Shenzhen Neptunus Interlong Bio-Technique Recent Development

11.16 Tonghua Dongbao Pharmaceutical

11.16.1 Tonghua Dongbao Pharmaceutical Company Details

11.16.2 Tonghua Dongbao Pharmaceutical Business Overview

11.16.3 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Introduction

11.16.4 Tonghua Dongbao Pharmaceutical Revenue in Biotechnological Drugs Business (2020-2025)

11.16.5 Tonghua Dongbao Pharmaceutical Recent Development

11.17 Torrent Pharmaceuticals

11.17.1 Torrent Pharmaceuticals Company Details

11.17.2 Torrent Pharmaceuticals Business Overview

11.17.3 Torrent Pharmaceuticals Biotechnological Drugs Introduction

11.17.4 Torrent Pharmaceuticals Revenue in Biotechnological Drugs Business (2020-2025)

11.17.5 Torrent Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

3SBio Inc

Anhui Anke Biotechnology

Beijing SL Pharmaceutical

Biotech Pharmaceutical

Cadila Healthcare

Celgen Biopharma

Celltrion

Dr. Reddy's

GeneScience Pharmaceuticals

Hisun Pharma

Jiangsu Sihuan Bioengineering

Novartis (Sandoz)

Pfizer (Hospira)

Shanghai Lansheng Guojian Pharmaceutical

Shenzhen Neptunus Interlong Bio-Technique

Tonghua Dongbao Pharmaceutical

Torrent Pharmaceuticals

List of Tables

Table 1. Global Biotechnological Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Genetically Engineered Drugs

Table 3. Key Players of Therapeutic Monoclonal Antibody Drugs

Table 4. Key Players of Gene Therapy and Nucleic Acid Drugs

Table 5. Key Players of Genetically Engineered Vaccines

Table 6. Key Players of Other

Table 7. Global Biotechnological Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Biotechnological Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Biotechnological Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Biotechnological Drugs Market Share by Region (2020-2025)

Table 11. Global Biotechnological Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Biotechnological Drugs Market Share by Region (2026-2031)

Table 13. Biotechnological Drugs Market Trends

Table 14. Biotechnological Drugs Market Drivers

Table 15. Biotechnological Drugs Market Challenges

Table 16. Biotechnological Drugs Market Restraints

Table 17. Global Biotechnological Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Biotechnological Drugs Market Share by Players (2020-2025)

Table 19. Global Top Biotechnological Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotechnological Drugs as of 2024)

Table 20. Ranking of Global Top Biotechnological Drugs Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Biotechnological Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Biotechnological Drugs, Headquarters and Area Served

Table 23. Global Key Players of Biotechnological Drugs, Product and Application

Table 24. Global Key Players of Biotechnological Drugs, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Biotechnological Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Biotechnological Drugs Revenue Market Share by Type (2020-2025)

Table 28. Global Biotechnological Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Biotechnological Drugs Revenue Market Share by Type (2026-2031)

Table 30. Global Biotechnological Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Biotechnological Drugs Revenue Market Share by Application (2020-2025)

Table 32. Global Biotechnological Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Biotechnological Drugs Revenue Market Share by Application (2026-2031)

Table 34. North America Biotechnological Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Biotechnological Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Biotechnological Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Biotechnological Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Biotechnological Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Biotechnological Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Biotechnological Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Biotechnological Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Biotechnological Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Biotechnological Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Biotechnological Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Biotechnological Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Biotechnological Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Biotechnological Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Biotechnological Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 49. 3SBIO Company Details

Table 50. 3SBIO Business Overview

Table 51. 3SBIO Biotechnological Drugs Product

Table 52. 3SBIO Revenue in Biotechnological Drugs Business (2020-2025) & (US$ Million)

Table 53. 3SBIO Recent Development

Table 54. Anhui Anke Biotechnology Company Details

Table 55. Anhui Anke Biotechnology Business Overview

Table 56. Anhui Anke Biotechnology Biotechnological Drugs Product

Table 57. Anhui Anke Biotechnology Revenue in Biotechnological Drugs Business (2020-2025) & (US$ Million)

Table 58. Anhui Anke Biotechnology Recent Development

Table 59. Beijing SL Pharmaceutical Company Details

Table 60. Beijing SL Pharmaceutical Business Overview

Table 61. Beijing SL Pharmaceutical Biotechnological Drugs Product

Table 62. Beijing SL Pharmaceutical Revenue in Biotechnological Drugs Business (2020-2025) & (US$ Million)

Table 63. Beijing SL Pharmaceutical Recent Development

Table 64. Biotech Pharmaceutical Company Details

Table 65. Biotech Pharmaceutical Business Overview

Table 66. Biotech Pharmaceutical Biotechnological Drugs Product

Table 67. Biotech Pharmaceutical Revenue in Biotechnological Drugs Business (2020-2025) & (US$ Million)

Table 68. Biotech Pharmaceutical Recent Development

Table 69. Cadila Healthcare Company Details

Table 70. Cadila Healthcare Business Overview

Table 71. Cadila Healthcare Biotechnological Drugs Product

Table 72. Cadila Healthcare Revenue in Biotechnological Drugs Business (2020-2025) & (US$ Million)

Table 73. Cadila Healthcare Recent Development

Table 74. Celgen Biopharma Company Details

Table 75. Celgen Biopharma Business Overview

Table 76. Celgen Biopharma Biotechnological Drugs Product

Table 77. Celgen Biopharma Revenue in Biotechnological Drugs Business (2020-2025) & (US$ Million)

Table 78. Celgen Biopharma Recent Development

Table 79. Celltrion Company Details

Table 80. Celltrion Business Overview

Table 81. Celltrion Biotechnological Drugs Product

Table 82. Celltrion Revenue in Biotechnological Drugs Business (2020-2025) & (US$ Million)

Table 83. Celltrion Recent Development

Table 84. Dr Reddy’s Company Details

Table 85. Dr Reddy’s Business Overview

Table 86. Dr Reddy’s Biotechnological Drugs Product

Table 87. Dr Reddy’s Revenue in Biotechnological Drugs Business (2020-2025) & (US$ Million)

Table 88. Dr Reddy’s Recent Development

Table 89. GeneScience Pharmaceuticals Company Details

Table 90. GeneScience Pharmaceuticals Business Overview

Table 91. GeneScience Pharmaceuticals Biotechnological Drugs Product

Table 92. GeneScience Pharmaceuticals Revenue in Biotechnological Drugs Business (2020-2025) & (US$ Million)

Table 93. GeneScience Pharmaceuticals Recent Development

Table 94. Hisun Pharma Company Details

Table 95. Hisun Pharma Business Overview

Table 96. Hisun Pharma Biotechnological Drugs Product

Table 97. Hisun Pharma Revenue in Biotechnological Drugs Business (2020-2025) & (US$ Million)

Table 98. Hisun Pharma Recent Development

Table 99. Jiangsu Sihuan Bioengineering Company Details

Table 100. Jiangsu Sihuan Bioengineering Business Overview

Table 101. Jiangsu Sihuan Bioengineering Biotechnological Drugs Product

Table 102. Jiangsu Sihuan Bioengineering Revenue in Biotechnological Drugs Business (2020-2025) & (US$ Million)

Table 103. Jiangsu Sihuan Bioengineering Recent Development

Table 104. Novartis (Sandoz) Company Details

Table 105. Novartis (Sandoz) Business Overview

Table 106. Novartis (Sandoz) Biotechnological Drugs Product

Table 107. Novartis (Sandoz) Revenue in Biotechnological Drugs Business (2020-2025) & (US$ Million)

Table 108. Novartis (Sandoz) Recent Development

Table 109. Pfizer (Hospira) Company Details

Table 110. Pfizer (Hospira) Business Overview

Table 111. Pfizer (Hospira) Biotechnological Drugs Product

Table 112. Pfizer (Hospira) Revenue in Biotechnological Drugs Business (2020-2025) & (US$ Million)

Table 113. Pfizer (Hospira) Recent Development

Table 114. Shanghai Lansheng Guojian Pharmaceutical Company Details

Table 115. Shanghai Lansheng Guojian Pharmaceutical Business Overview

Table 116. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product

Table 117. Shanghai Lansheng Guojian Pharmaceutical Revenue in Biotechnological Drugs Business (2020-2025) & (US$ Million)

Table 118. Shanghai Lansheng Guojian Pharmaceutical Recent Development

Table 119. Shenzhen Neptunus Interlong Bio-Technique Company Details

Table 120. Shenzhen Neptunus Interlong Bio-Technique Business Overview

Table 121. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product

Table 122. Shenzhen Neptunus Interlong Bio-Technique Revenue in Biotechnological Drugs Business (2020-2025) & (US$ Million)

Table 123. Shenzhen Neptunus Interlong Bio-Technique Recent Development

Table 124. Tonghua Dongbao Pharmaceutical Company Details

Table 125. Tonghua Dongbao Pharmaceutical Business Overview

Table 126. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product

Table 127. Tonghua Dongbao Pharmaceutical Revenue in Biotechnological Drugs Business (2020-2025) & (US$ Million)

Table 128. Tonghua Dongbao Pharmaceutical Recent Development

Table 129. Torrent Pharmaceuticals Company Details

Table 130. Torrent Pharmaceuticals Business Overview

Table 131. Torrent Pharmaceuticals Biotechnological Drugs Product

Table 132. Torrent Pharmaceuticals Revenue in Biotechnological Drugs Business (2020-2025) & (US$ Million)

Table 133. Torrent Pharmaceuticals Recent Development

Table 134. Research Programs/Design for This Report

Table 135. Key Data Information from Secondary Sources

Table 136. Key Data Information from Primary Sources

Table 137. Authors List of This Report

List of Figures

Figure 1. Biotechnological Drugs Picture

Figure 2. Global Biotechnological Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Biotechnological Drugs Market Share by Type: 2024 VS 2031

Figure 4. Genetically Engineered Drugs Features

Figure 5. Therapeutic Monoclonal Antibody Drugs Features

Figure 6. Gene Therapy and Nucleic Acid Drugs Features

Figure 7. Genetically Engineered Vaccines Features

Figure 8. Other Features

Figure 9. Global Biotechnological Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Biotechnological Drugs Market Share by Application: 2024 VS 2031

Figure 11. Tumor Case Studies

Figure 12. Autoimmune Disease Case Studies

Figure 13. Other Case Studies

Figure 14. Biotechnological Drugs Report Years Considered

Figure 15. Global Biotechnological Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Biotechnological Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Biotechnological Drugs Market Share by Region: 2024 VS 2031

Figure 18. Global Biotechnological Drugs Market Share by Players in 2024

Figure 19. Global Top Biotechnological Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotechnological Drugs as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Biotechnological Drugs Revenue in 2024

Figure 21. North America Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Biotechnological Drugs Market Share by Country (2020-2031)

Figure 23. United States Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Biotechnological Drugs Market Share by Country (2020-2031)

Figure 27. Germany Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Biotechnological Drugs Market Share by Region (2020-2031)

Figure 35. China Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Biotechnological Drugs Market Share by Country (2020-2031)

Figure 43. Mexico Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Biotechnological Drugs Market Share by Country (2020-2031)

Figure 47. Turkey Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Biotechnological Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. 3SBIO Revenue Growth Rate in Biotechnological Drugs Business (2020-2025)

Figure 51. Anhui Anke Biotechnology Revenue Growth Rate in Biotechnological Drugs Business (2020-2025)

Figure 52. Beijing SL Pharmaceutical Revenue Growth Rate in Biotechnological Drugs Business (2020-2025)

Figure 53. Biotech Pharmaceutical Revenue Growth Rate in Biotechnological Drugs Business (2020-2025)

Figure 54. Cadila Healthcare Revenue Growth Rate in Biotechnological Drugs Business (2020-2025)

Figure 55. Celgen Biopharma Revenue Growth Rate in Biotechnological Drugs Business (2020-2025)

Figure 56. Celltrion Revenue Growth Rate in Biotechnological Drugs Business (2020-2025)

Figure 57. Dr Reddy’s Revenue Growth Rate in Biotechnological Drugs Business (2020-2025)

Figure 58. GeneScience Pharmaceuticals Revenue Growth Rate in Biotechnological Drugs Business (2020-2025)

Figure 59. Hisun Pharma Revenue Growth Rate in Biotechnological Drugs Business (2020-2025)

Figure 60. Jiangsu Sihuan Bioengineering Revenue Growth Rate in Biotechnological Drugs Business (2020-2025)

Figure 61. Novartis (Sandoz) Revenue Growth Rate in Biotechnological Drugs Business (2020-2025)

Figure 62. Pfizer (Hospira) Revenue Growth Rate in Biotechnological Drugs Business (2020-2025)

Figure 63. Shanghai Lansheng Guojian Pharmaceutical Revenue Growth Rate in Biotechnological Drugs Business (2020-2025)

Figure 64. Shenzhen Neptunus Interlong Bio-Technique Revenue Growth Rate in Biotechnological Drugs Business (2020-2025)

Figure 65. Tonghua Dongbao Pharmaceutical Revenue Growth Rate in Biotechnological Drugs Business (2020-2025)

Figure 66. Torrent Pharmaceuticals Revenue Growth Rate in Biotechnological Drugs Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Biologic Medical Product Market Research Report 2025

Global Living Biological Drugs Market Research Report 2025

Biologic Therapeutic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Live Biotherapeutic Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biologics Drug Discovery Market Research Report 2024

Global Innovations in Biologics and Biosimilars Market Research Report 2024

Biotherapeutics Cell Line Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Genome Based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Genetically Engineered Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biotech Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biologics and Biosimilars Market Research Report 2025

Pharmaceuticals and Biotechnology R D Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene Therapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Microbial Fermentation Technology for Bio Pharmaceutical Industries Market

Automation in Biopharma Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharma and Biotech Clinical Stage Partnering Terms and Agreements Directory Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions